Pfizer Inc (PFE)

$26.81 -0.24 (-0.89%)
Market Cap 153.81B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.24
Forward PE 8.95
Profit Margin 12.42%
Debt to Equity Ratio 0.75
Volume 42,789,500
Avg Vol 45,364,313
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 42%
Beta 0.47
Analysts Sell
Price Target $28.82

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
Stocktwits
Stocktwits Mar. 10 at 3:58 PM
BioNTech co-founders launching a new mRNA innovation company, while Pfizer reportedly sells part of its stake. $BNTX $PFE
0 · Reply
JonCollins
JonCollins Mar. 10 at 3:45 PM
$PFE pushing past 1 year high. Will load more if we dip below 25.00 again this year.
1 · Reply
Heavysacks
Heavysacks Mar. 10 at 3:40 PM
$PFE
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Mar. 10 at 3:40 PM
$PFE, what is you doing? You’re being very Pfizern’t
1 · Reply
doubleuptwice
doubleuptwice Mar. 10 at 3:33 PM
$PFE I have to be in the top 1% of all traders when it comes to chart reading.
1 · Reply
garygarcia5
garygarcia5 Mar. 10 at 3:32 PM
$PFE The market is embarking on a short-squeeze rally.
0 · Reply
Jack90
Jack90 Mar. 10 at 2:51 PM
$NKE $PFE undervalued Adding long
0 · Reply
doubleuptwice
doubleuptwice Mar. 10 at 2:10 PM
$PFE we should start to fly here
1 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 10 at 1:36 PM
$PFE it’s just so damn bad
0 · Reply
AndyR22
AndyR22 Mar. 10 at 12:56 PM
$CRMD I'm done adding when this drops....so now it will probably skyrocket. I'm putting extra money in $PFE now.
0 · Reply
Latest News on PFE
Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Mar 9, 2026, 7:27 AM EDT - 1 day ago

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

Mar 9, 2026, 6:45 AM EDT - 1 day ago

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (March 2026)

Mar 7, 2026, 8:15 AM EST - 3 days ago

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (March 2026)

ADP ARCC BX CAG GLPI MPLX MSFT

Wall Street Breakfast Podcast: India To Buy Russian Oil As War Disrupts Supplies

Mar 6, 2026, 6:05 AM EST - 4 days ago

Wall Street Breakfast Podcast: India To Buy Russian Oil As War Disrupts Supplies

AMD GOOG GOOGL LLY NVDA NVO

China approves Pfizer GLP-1 drug for weight management

Mar 6, 2026, 12:40 AM EST - 4 days ago

China approves Pfizer GLP-1 drug for weight management

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

Mar 5, 2026, 4:48 PM EST - 4 days ago

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

Seven S&P500 Ideal 'Safer' March Dividend Dogs

Mar 4, 2026, 11:31 AM EST - 5 days ago

Seven S&P500 Ideal 'Safer' March Dividend Dogs

AMCR ARE BBY BEN BXP CAG CCI

Pfizer's Portfolio Renewal In Progress - High Yields For The Patient

Mar 4, 2026, 9:09 AM EST - 6 days ago

Pfizer's Portfolio Renewal In Progress - High Yields For The Patient

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

Mar 4, 2026, 8:55 AM EST - 6 days ago

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

SMWB

Pfizer's Quiet Cash Comeback

Mar 3, 2026, 9:50 AM EST - 7 days ago

Pfizer's Quiet Cash Comeback

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields

Mar 3, 2026, 8:10 AM EST - 7 days ago

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields

PRGO XRAY

Pfizer Inc. (PFE) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Mar 2, 2026, 1:27 PM EST - 7 days ago

Pfizer Inc. (PFE) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Pfizer CEO flags issues with FDA's vaccine leadership

Mar 2, 2026, 11:14 AM EST - 7 days ago

Pfizer CEO flags issues with FDA's vaccine leadership

The High Dividend Yield Bull Market: 3 Compelling 6% Yields

Mar 2, 2026, 4:51 AM EST - 8 days ago

The High Dividend Yield Bull Market: 3 Compelling 6% Yields

ABBV AMGN AVGO BTI DIV ENB GTY

14 Ideal 'Safer' Dividend Buys From 29 Of 69 March Graham Value All-Stars (GVAS)

Mar 1, 2026, 8:10 AM EST - 9 days ago

14 Ideal 'Safer' Dividend Buys From 29 Of 69 March Graham Value All-Stars (GVAS)

ARCC BBVA E EQNR ETD FINV GSL

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

Feb 27, 2026, 10:00 AM EST - 11 days ago

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

5 'Safer' Dividend Buys In Barron's 23 Better February Bets Than T-Bills

Feb 26, 2026, 7:48 AM EST - 12 days ago

5 'Safer' Dividend Buys In Barron's 23 Better February Bets Than T-Bills

BBY CAG EQR FRT KEY KMI LYB

U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Feb 24, 2026, 2:29 PM EST - 13 days ago

U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Feb 24, 2026, 7:45 AM EST - 14 days ago

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Pfizer in diabetes drug deal with Sciwind Biosciences

Feb 23, 2026, 10:26 PM EST - 14 days ago

Pfizer in diabetes drug deal with Sciwind Biosciences

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

Feb 23, 2026, 3:15 PM EST - 14 days ago

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

MRK MRNA

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Feb 23, 2026, 10:00 AM EST - 15 days ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer: A Risky 6.3% Yield For Income-Oriented Investors

Feb 20, 2026, 11:47 PM EST - 17 days ago

Pfizer: A Risky 6.3% Yield For Income-Oriented Investors

Is There 25% Downside For Pfizer Stock?

Feb 18, 2026, 12:00 PM EST - 19 days ago

Is There 25% Downside For Pfizer Stock?

Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game

Feb 18, 2026, 11:30 AM EST - 19 days ago

Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game

Pfizer: The Rebound Looks Unsustainable

Feb 17, 2026, 5:42 PM EST - 20 days ago

Pfizer: The Rebound Looks Unsustainable

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Feb 17, 2026, 6:45 AM EST - 21 days ago

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Prices, pipelines and patent cliffs: Inside pharma's big reset

Feb 13, 2026, 6:13 AM EST - 25 days ago

Prices, pipelines and patent cliffs: Inside pharma's big reset

AMGN LLY NVO

These 32 favorite stocks signal the bull market is running on fumes

Feb 12, 2026, 8:05 AM EST - 26 days ago

These 32 favorite stocks signal the bull market is running on fumes

AAPL ABT ADBE AMGN AVGO BAC BK

Pfizer: A Great Opportunity Post Earnings

Feb 11, 2026, 6:08 PM EST - 26 days ago

Pfizer: A Great Opportunity Post Earnings

2 Urgent Sells And 2 No Brainer Dividend Buys

Feb 11, 2026, 4:06 PM EST - 26 days ago

2 Urgent Sells And 2 No Brainer Dividend Buys

ABBV AEP AMGN BMY ESS HASI HD

Is Pfizer Stock Now A Value Trap?

Feb 11, 2026, 8:56 AM EST - 27 days ago

Is Pfizer Stock Now A Value Trap?

Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund

Feb 10, 2026, 3:20 PM EST - 27 days ago

Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund

Pfizer: 'Hold' As Patent Cliff Looms, Along With Need For Differentiating Factor In Obesity

Feb 8, 2026, 10:19 PM EST - 4 weeks ago

Pfizer: 'Hold' As Patent Cliff Looms, Along With Need For Differentiating Factor In Obesity

Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

Feb 6, 2026, 2:55 PM EST - 4 weeks ago

Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

14 Ideal 'Safer' Dividend Buys From 29 Of 69 February Graham Value All-Stars (GVAS)

Feb 6, 2026, 7:25 AM EST - 4 weeks ago

14 Ideal 'Safer' Dividend Buys From 29 Of 69 February Graham Value All-Stars (GVAS)

ARCC ARLP CNQ EPD EQNR F FINV

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

Feb 6, 2026, 6:45 AM EST - 4 weeks ago

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

Feb 5, 2026, 7:09 PM EST - 4 weeks ago

Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

Pfizer Inc. (PFE) Q4 2025 Earnings Call Transcript

Feb 3, 2026, 3:00 PM EST - 4 weeks ago

Pfizer Inc. (PFE) Q4 2025 Earnings Call Transcript

Pfizer: Messy Q4 Earnings Mask An Improving Business

Feb 3, 2026, 2:02 PM EST - 4 weeks ago

Pfizer: Messy Q4 Earnings Mask An Improving Business

Obesity stocks slump on Novo's underwhelming 2026 sales forecast

Feb 3, 2026, 1:27 PM EST - 4 weeks ago

Obesity stocks slump on Novo's underwhelming 2026 sales forecast

ALT AMGN GPCR LLY NVO VKTX

Silver Surges Over 15%; Pfizer Earnings Top Views

Feb 3, 2026, 12:00 PM EST - 4 weeks ago

Silver Surges Over 15%; Pfizer Earnings Top Views

Pfizer Q4 Earnings Review: This Classic Value Trap Remains As Tempting As Ever

Feb 3, 2026, 11:56 AM EST - 4 weeks ago

Pfizer Q4 Earnings Review: This Classic Value Trap Remains As Tempting As Ever

Pfizer, Merck report Q4 results: Citi's Geoff Meacham on key takeaways

Feb 3, 2026, 11:17 AM EST - 4 weeks ago

Pfizer, Merck report Q4 results: Citi's Geoff Meacham on key takeaways

MRK

Pfizer beats quarterly estimates despite Covid product decline - reaffirms modest outlook

Feb 3, 2026, 10:15 AM EST - 5 weeks ago

Pfizer beats quarterly estimates despite Covid product decline - reaffirms modest outlook

Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops

Feb 3, 2026, 8:50 AM EST - 5 weeks ago

Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops

Pfizer maps post-Covid reset with obesity trials and deep cost cuts

Feb 3, 2026, 8:17 AM EST - 5 weeks ago

Pfizer maps post-Covid reset with obesity trials and deep cost cuts

Pfizer says once-a-month weight-loss drug works as it forecasts profit decline

Feb 3, 2026, 7:28 AM EST - 5 weeks ago

Pfizer says once-a-month weight-loss drug works as it forecasts profit decline

Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand

Feb 3, 2026, 7:21 AM EST - 5 weeks ago

Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand

Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

Feb 3, 2026, 7:18 AM EST - 5 weeks ago

Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

Stocktwits
Stocktwits Mar. 10 at 3:58 PM
BioNTech co-founders launching a new mRNA innovation company, while Pfizer reportedly sells part of its stake. $BNTX $PFE
0 · Reply
JonCollins
JonCollins Mar. 10 at 3:45 PM
$PFE pushing past 1 year high. Will load more if we dip below 25.00 again this year.
1 · Reply
Heavysacks
Heavysacks Mar. 10 at 3:40 PM
$PFE
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Mar. 10 at 3:40 PM
$PFE, what is you doing? You’re being very Pfizern’t
1 · Reply
doubleuptwice
doubleuptwice Mar. 10 at 3:33 PM
$PFE I have to be in the top 1% of all traders when it comes to chart reading.
1 · Reply
garygarcia5
garygarcia5 Mar. 10 at 3:32 PM
$PFE The market is embarking on a short-squeeze rally.
0 · Reply
Jack90
Jack90 Mar. 10 at 2:51 PM
$NKE $PFE undervalued Adding long
0 · Reply
doubleuptwice
doubleuptwice Mar. 10 at 2:10 PM
$PFE we should start to fly here
1 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 10 at 1:36 PM
$PFE it’s just so damn bad
0 · Reply
AndyR22
AndyR22 Mar. 10 at 12:56 PM
$CRMD I'm done adding when this drops....so now it will probably skyrocket. I'm putting extra money in $PFE now.
0 · Reply
TheDizPlinTrader
TheDizPlinTrader Mar. 10 at 12:54 PM
$PFE 💊 1 Hour Levels Price: $26.74 Support: $26.10 Resistance: $27.60 👉 Tap follow to keep these 1-hour levels on your feed.
0 · Reply
topstockalerts
topstockalerts Mar. 10 at 12:50 PM
Shares of BioNTech fell after the company reported a quarterly loss and issued a weak outlook for 2026. The drugmaker posted a loss of €1.25 per share on revenue of €907.4 million in the fourth quarter, compared with expectations for a smaller €0.45 loss. Net loss totaled €305 million, versus a profit of €259.5 million a year earlier. The company expects 2026 revenue of €2 billion to €2.3 billion, below analysts’ forecasts of €2.75 billion. It also anticipates declining revenue from its Covid-19 vaccine developed with Pfizer as demand weakens in the U.S. and Europe. Adding to the pressure, the firm announced that its co-founders plan to leave by the end of the year to launch a new biotech startup. Following the results, BioNTech ADRs fell about 15% in premarket trading while futures on the S&P 500 edged higher. $BNTX $SPX $PFE
0 · Reply
DocPharm
DocPharm Mar. 10 at 12:29 PM
$BNTX $ABUS $PFE $ROIV BIG OL’ HMMMMM RIGHT HERE
2 · Reply
CarloRobertson
CarloRobertson Mar. 10 at 12:05 PM
Pipeline progress meets steady yield. $PFE
0 · Reply
dewmoore
dewmoore Mar. 10 at 11:40 AM
$SLS Marty the CRIMINAL got me robbing my piggy bank! AGAIN! lol --- I'll take 3k + 2k = 5k MORE even at these prices!!!!! I told you the CURRENT floor is $35.29 ! Gilead was so desperate for AML they paid $6B (todays adjust for inflation)4 a Drug that fucking FAILED/2024 (magrolimab) SLS is NOT chopped liver LOL!!!!! I will scoop up ANYTHING under $10 !!!! Next week I might mortgage the home that's how confident I am of $SLS Who will BID first??? LOL !!! LFG $PFE $MRK $LLY $ABBV It's WIN o'clock! baby
0 · Reply
Iam4our
Iam4our Mar. 10 at 9:52 AM
$PFE $22? Revisit Bottom BB.
0 · Reply
Paulzk
Paulzk Mar. 10 at 5:10 AM
$PFE For the last three months of 2025, Pfizer actually incurred a loss, and its earnings per share (EPS) were a negative $0.29. This was due to asset impairment charges totaling around $4.4 billion. Pfizer's full-year EPS was $1.36, which was down from $1.41 in the previous year. However, in both 2025 and 2024, the pharmaceutical company incurred billions in impairment charges, which adversely impacted its bottom line. Thus, given this context, its financial performance is better than what its EPS would indicate. For now, Pfizer's dividend still looks safe simply because its financials aren't as bad as they look due to non-cash impairment charges https://finance.yahoo.com/news/pfizers-payout-ratio-still-over-182000057.html
0 · Reply
DragonAlgo
DragonAlgo Mar. 10 at 4:06 AM
🐉 $PFE CALL — DragonAlgo® Signal Contract: PFE CALL Expiry: 2026-03-13 | Strike: $27.00 | Type: CALL Option Plan (premium): Entry: $0.24 Stop: $0.17 TP1: $0.31 TP2: $0.41 TP3: $0.58 Momentum tape remains active. 🔗 https://dragonalgo.com
0 · Reply
dust6431
dust6431 Mar. 10 at 3:49 AM
$PFE As Dr Dre would say, Still
0 · Reply
sam92
sam92 Mar. 9 at 10:59 PM
$PFE Pfizer reports positive data from a Phase 2 study for the atopic dermatitis antibody https://seekingalpha.com/news/4562341-pfizer-reports-positive-data-from-phase-2-study-for-atopic-dermatitis-antibody?share_source=shared_news?source=emailshare
0 · Reply
frankwhite718
frankwhite718 Mar. 9 at 10:49 PM
$PFE i had to exit pfe butt i see she hasnt done much since. Waiting to see if this iran drama corrects market so i can go long again. Miss my divvey.
1 · Reply
Framingtheworld
Framingtheworld Mar. 9 at 10:22 PM
$HELP this is worth at least $1 billion if $ATAI trying to sell one drug for $2 billion lmao. Plus help just hired former $PFE executive director. This is crazy undervalued and has more assets than all of the other psyc companies I believe
1 · Reply